AROC fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
AroCell AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. Its products include AroCell TK 210 ELISA, which was designed for simple, robust, and scalable measurement of Thymidine Kinase 1 in blood samples. The company was founded by Karl Axel Staffan Eriksson, Arne Ferstad, Qi Min He, Per Nils Jesper Matsson, Sven Skog, and Bernhard Tribukait in 2003 and is headquartered in Stockholm, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
AROC has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company